These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34967083)

  • 1. Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.
    Shepheard SR; Karnaros V; Benyamin B; Schultz DW; Dubowsky M; Wuu J; Chataway T; Malaspina A; Benatar M; Rogers ML
    Eur J Neurol; 2022 Apr; 29(4):990-999. PubMed ID: 34967083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary p75
    Shepheard SR; Wuu J; Cardoso M; Wiklendt L; Dinning PG; Chataway T; Schultz D; Benatar M; Rogers ML
    Neurology; 2017 Mar; 88(12):1137-1143. PubMed ID: 28228570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis.
    Shepheard SR; Chataway T; Schultz DW; Rush RA; Rogers ML
    PLoS One; 2014; 9(1):e87398. PubMed ID: 24475283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary p75
    Shi G; Shao S; Zhou J; Huang K; Bi FF
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):438-445. PubMed ID: 34726989
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort.
    Jia R; Shepheard S; Jin J; Hu F; Zhao X; Xue L; Xiang L; Qi H; Qu Q; Guo F; Rogers ML; Dang J
    Sci Rep; 2017 Jul; 7(1):5127. PubMed ID: 28698670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis.
    Yamada S; Hashizume A; Hijikata Y; Ito D; Kishimoto Y; Iida M; Koike H; Hirakawa A; Katsuno M
    J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1072-1079. PubMed ID: 33737450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis.
    Lunetta C; Lizio A; Gerardi F; Tarlarini C; Filippi M; Riva N; Tremolizzo L; Diamanti S; Dellanoce CC; Mosca L; Sansone VA; Campolo J
    J Neurol; 2020 Dec; 267(12):3609-3616. PubMed ID: 32638112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with amyotrophic lateral sclerosis.
    Holdom CJ; Janse van Mantgem MR; van Eijk RPA; Howe SL; van den Berg LH; McCombe PA; Henderson RD; Ngo ST; Steyn FJ
    Eur J Neurol; 2021 Nov; 28(11):3615-3625. PubMed ID: 34216521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis.
    Donini L; Tanel R; Zuccarino R; Basso M
    Neurosci Res; 2023 Dec; 197():31-41. PubMed ID: 37689321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis.
    Lanznaster D; Bejan-Angoulvant T; Patin F; Andres CR; Vourc'h P; Corcia P; Blasco H
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):199-206. PubMed ID: 30961401
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis.
    Ikenaka K; Maeda Y; Hotta Y; Nagano S; Yamada S; Ito D; Torii R; Kakuda K; Tatebe H; Atsuta N; Aguirre C; Kimura Y; Baba K; Tokuda T; Katsuno M; Kimura K; Sobue G; Mochizuki H
    Eur J Neurol; 2022 May; 29(5):1410-1416. PubMed ID: 35128793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low plasma hyaluronan is associated with faster functional decline in patients with amyotrophic lateral sclerosis.
    Holdom CJ; Ngo ST; McCombe PA; Henderson RD; Steyn FJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Feb; 23(1-2):42-48. PubMed ID: 34569358
    [No Abstract]   [Full Text] [Related]  

  • 14. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis.
    Agnello L; Colletti T; Lo Sasso B; Vidali M; Spataro R; Gambino CM; Giglio RV; Piccoli T; Bivona G; La Bella V; Ciaccio M
    Eur J Neurol; 2021 Jun; 28(6):1868-1875. PubMed ID: 33638255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
    Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
    Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Murray SS; Piccenna LG; Lopes EC; Kilpatrick TJ; Cheema SS
    J Neurosci Res; 2004 Oct; 78(2):193-9. PubMed ID: 15378612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
    Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
    Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis.
    Gentile F; Maranzano A; Verde F; Bettoni V; Colombo E; Doretti A; Olivero M; Scheveger F; Colombrita C; Bulgarelli I; Spinelli EG; Torresani E; Messina S; Maderna L; Agosta F; Morelli C; Filippi M; Silani V; Ticozzi N
    J Neurol; 2024 Feb; 271(2):794-803. PubMed ID: 37801095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis.
    Guo QF; Hu W; Xu LQ; Luo H; Wang N; Zhang QJ
    Ann Clin Transl Neurol; 2021 Feb; 8(2):448-455. PubMed ID: 33449454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
    Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G;
    JAMA Neurol; 2014 Sep; 71(9):1134-42. PubMed ID: 25048026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.